[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsControl group: In the control group, routine treatment as (hydroxychlroquine (400 milligram stat then 200 miligram BID)+sofosbuvir/daclatasvir (400/60 milligram)), for 7-10 days, will be administered.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: In the intervention group,oral PTX (400 milligram TDS for up to 2 weeks) will be added to the routine treatment (hydroxychlroquine (400 milligram stat then 200 miligram BID)+sofosbuvir/daclatasvir (400/60 milligram)), for 7-10 days.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 971, "treatment_name": "Pentoxifylline", "treatment_type": "Cardiovascular agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]